|
業務類別
|
Biotechnology |
|
業務概覽
|
Protalix BioTherapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, production, and commercialization of therapeutics for rare diseases with important unmet needs. ProCellEx, a proprietary plant cell-based protein expression system, represents a new method for developing recombinant proteins in an industrial-scale manner. corporate includes the development of treatments for rare and orphan diseases. The Company operates as a single operating segment in Israel. |
| 公司地址
| 2 University Plaza, Suite 100, Hackensack, NJ, USA, 07601 |
| 電話號碼
| +1 201 696-9345 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.protalix.com |
| 員工數量
| 226 |
| Mr. Dror Bashan |
Director, President and Chief Executive Officer |
美元 374.11K |
18/03/2026 |
| Mr. Yaron Naos |
Chief Operating Officer |
美元 215.55K |
18/03/2026 |
| Mr. Gilad Mamlok |
Principal Accounting Officer, Chief Financial Officer, Treasurer and Secretary |
-- |
18/03/2026 |
|
|
| Mr. Dror Bashan |
Director, President and Chief Executive Officer |
18/03/2026 |
| Dr. Eliot Richard Forster, M.B.A.,PhD |
Chairman of the Board |
18/03/2026 |
| Ms. Gwen A. Melincoff |
Independent Director |
18/03/2026 |
| Dr. Shmuel Ben-Zvi, PhD |
Independent Director |
18/03/2026 |
| Dr. Pol F. Boudes,M.D. |
Independent Director |
18/03/2026 |
| Mr. Amos Bar Shalev |
Independent Director |
18/03/2026 |
| Dr. Aharon Schwartz,PhD |
Independent Director |
18/03/2026 |
| Mr. Christian Elze |
Director |
18/03/2026 |
|
|
|
|
